683 Capital Management’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $7.86K | Hold |
|
|||||
|
2024
Q2 | $25.2K | Sell |
|
|||||
|
2024
Q1 | $31.2K | Hold |
|
|||||
|
2023
Q4 | $30K | Hold |
|
|||||
|
2023
Q3 | $132K | Hold |
|
|||||
|
2023
Q2 | $78K | Hold |
|
|||||
|
2023
Q1 | $24.6K | Hold |
|
|||||
|
2022
Q4 | $30K | Hold |
|
|||||
|
2022
Q3 | $33K | Hold |
|
|||||
|
2022
Q2 | $54K | Hold |
|
|||||
|
2022
Q1 | $216K | Buy |
|
|||||
|
2021
Q4 | $51K | Buy |
|